SCHEMBL15413369

SCHEMBL15413369

CCC(=O)CNC(=O)CNC(=O)CNC(=O)C(CCc1ccccc1)NC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSS P25774 2/20 0.46
▸ CTSK P43235 2/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA3 P07451 1/20 0.46
▸ CA4 P22748 1/20 0.46
▸ CA6 P23280 1/20 0.46
▸ CA5A P35218 1/20 0.46
▸ CA7 P43166 1/20 0.46
▸ CACNA1C Q13936 1/20 0.46
▸ SCN9A Q15858 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ CA13 Q8N1Q1 1/20 0.46
▸ CA14 Q9ULX7 1/20 0.46
▸ CA5B Q9Y2D0 1/20 0.46
▸ CHRNB2 P17787 1/20 0.45
▸ CHRNB4 P30926 1/20 0.45
▸ CHRNA3 P32297 1/20 0.45
▸ CHRNA4 P43681 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8271877 0.81 CPA1 (0.51) CTSSCTSKCA12CA1CA2
SCHEMBL8270567 0.78 CA12 (0.49) CTSSCTSKCA12CA1CA2
SCHEMBL23627513 0.77 CHRNB2 (0.48) CTSSCTSKCHRNB2CHRNB4CHRNA3
SCHEMBL24642302 0.76 CTSS (0.50) CTSSCTSKCHRNB2CHRNB4CHRNA3
SCHEMBL13626650 0.76 CHRNB2 (0.54) CTSSCTSKCHRNB2CHRNB4CHRNA3
SCHEMBL18477610 0.75 CTSS (0.49) CTSSCTSKCHRNB2CHRNB4CHRNA3
SCHEMBL6931278 0.74 GNPAT (0.57) CTSSCTSKCA12CA1CA2
SCHEMBL468905 0.74 GNPAT (0.57) CTSSCTSKCA12CA1CA2
SCHEMBL468907 0.74 GNPAT (0.57) CTSSCTSKCA12CA1CA2
SCHEMBL5125213 0.74 HDAC1 (0.55) CA1CA2CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2869820-A2 PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS Onyx Therapeutics, Inc. (US) 2015-05-13 — — EP disclosed
WO-2014011695-A2 PRODRUGS OF PEPTIDE EPOXY KETONE PROTEASE INHIBITORS ONYX THERAPEUTICS, INC. (US) 2014-01-16 — — WO disclosed
Send feedback